Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

arly 30%," said Steven W. King, president and CEO of Peregrine. "These accomplishments have allowed us to build significant value in our oncology clinical pipeline, to grow the value of our contract manufacturing business and to realize immediate value from our bavituximab anti-viral technology platform through our DTRA government contract. These achievements have created considerable momentum that we expect to maintain throughout the coming year."

Mr. King added, "We more than doubled our Avid contract manufacturing revenues and recorded more than $5 million in first-year revenues from a multi-year government contract to evaluate our bavituximab anti-viral platform for its broad spectrum potential to treat or prevent serious virus infections. At the same time, we advanced our bavituximab and Cotara clinical trials in FY 2009 while keeping R&D costs flat. These trials have already yielded very promising early results, and we are optimistic they will continue to yield positive results during the current fiscal year."

Mr. King continued, "This year we also made important progress in raising the profile of all three of our clinical programs among investors, potential partners and the medical community, and as a result, the pace of our partnering efforts has accelerated. Among the most significant developments driving this increased interest was the release of our first clinical data indicating that bavituximab may be a valuable new option for treating cancer. In three separate Phase II trials in combination with chemotherapy, bavituximab demonstrated encouraging signs of efficacy in patients with advanced breast cancer and advanced lung cancer. All three trials surpassed the requisite efficacy criteria for expansion of patient enrollment, which is now well underway. These trials, along with our Phase I bavituximab cancer study that recently completed patient enrollment, are helping to set the stage for advancing ba
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... flu were worse, ,we would have really been in ... -- The outbreak of the pandemic H1N1 swine flu ... respond to public health emergencies, a new report says. ... Health and the Robert Wood Johnson Foundation, also finds ... health system. , "The 2009 H1N1 outbreak is the ...
(Date:12/15/2009)... some sobering statistics concerning the parallel rise in diabetes and obesity ... means of combating this trend afflicting their workforce. , ... ... are climbing across America due in large part to the alarming ... Association has stated that the rate of diabetes could be cut ...
(Date:12/15/2009)... be leaders in the fight against malaria ... in online learning, the Masie Center and Blackboard ... ONE and Malaria No More announced ... "Malaria Griots" program, a dynamic education course that ... in the fight against malaria. ,, "In ...
(Date:12/15/2009)... BERWYN, Pa., Dec. 15 4R Systems, ... supply chain solutions which help retailers significantly increase ... chain decisions, announced today that The Vitamin Shoppe ... 2008. ,, "4R,s store and DC inventory solutions ... inventory efficiency and in-stocks over the last two ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4
... report by a UN official, warns the Asia-Pacific countries of ... The report also states that such an epidemic can only ... more to keep the younger generation off drugs. ... body fighting HIV/AIDS at least 70 per cent of HIV ...
... early stage of breast cancer, according to researchers. This could ... they reported in The Lancet Oncology journal. ,Ductal ... the milk ducts. This is a form of pre-cancer that ... outside. The usual way of treating such a pre-cancer is ...
... increase the number of seats in existing facilities to fill ... accommodate// the central government's proposed quota policy, says Chief Minister ... in medical institutions and open more institutes in the state," ... 4,000 doctors and this was the only to "adjust the ...
... cartels operating from Pakistan and Jammu and Kashmir, warns ... always been a transit point for illegal drug consignments ... Afghanistan and Pakistan", said Prafulsinh Sarvaiya, Superintendent of NCB., ... underworld gangs have now become a part of this ...
... Recent research in California has revealed that DDT can ... to the pesticide//. ,While DDT is currently banned ... expand its use to combat mosquitoes that spread malaria. ... of epidemiology and maternal and child health at the ...
... a new survey millions of British tourists face several health ... or anti malaria pills before they go abroad//. ... visited tropical countries on holiday over the last five years ... has claimed over a million lives worldwide each year, 16 ...
Other Medicine News:Health News:Developmental Delays in Infants Linked to DDT 2Health News:Tourists Face Health Risks by Missing Vaccinations 2
(Date:12/15/2009)... opportune time to find the best plan at the ... Through the end of the year, thousands ... about their health coverage. This is when the ... benefits they will sign up and pay for in ... part of this decision, says Independent Retail Pharmacist Steve ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Surgical and Medical Instrument Manufacturing Industry ...
(Date:12/15/2009)... Dec. 15 Waters Corporation (NYSE: ... Publisher(TM) (v.7.1 SR4), an electronic laboratory notebook solution ... a secure electronic repository that stores and manages ... database and is used to boost efficiency in ... the SAFE-BioPharma digital identity and signature standard. The ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 1Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 1BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 3Mario Badescu 26apos 3Bs Acne Spot Treatment Picked as ELLE Readers 26apos 3B Favorite 62569 1
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... on anti-arrhythmia data from the MERLIN,TIMI-36 study, have ... Cardiology (ESC) Congress 2007 taking place in Vienna, ... update session entitled, The Effect of Ranolazine, a,Novel ...
... Genetic testing can be,used to help personalize the ... research published in the,September 1, 2007, issue of ... This result represents one of the first applications ... medical care., Because individuals metabolize drugs differently, ...
Other Medicine Technology:CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3Genetics Determine Optimal Drug Dose of Common Anticoagulant 2Genetics Determine Optimal Drug Dose of Common Anticoagulant 3
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... its new multifunctional lithotripsy system Lithoskop. ... data management is the perfect symbiosis ... Lithoskop is an engineering masterpiece for ... applications like lithotripsy, endourology, urodiagnostics, percutaneous ...
... stimulator for the treatment of long bone ... stimulator is a useful adjunct for the ... planned or when patient compliance may be ... surgically implanted, patients are assured of therapeutic ...
... cataract surgery following refractive surgery grows larger ... for surgeons, as calculating IOL power for ... power following RK, ALK, PRK and LASIK ... or topography. For example, keratometry and simulated ...
Medicine Products: